MarketCap
Facebook
X
TelegramQuarterly report 2022-Q4
added 02-09-2023
Cardiovascular Systems Retained Earnings 2011-2026 | CSII
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Cardiovascular Systems
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -424 M | -381 M | -363 M | -330 M | -328 M | -329 M | -327 M | -271 M | -239 M | -203 M | -179 M | -162 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -162 M | -424 M | -295 M |
Quarterly Retained Earnings Cardiovascular Systems
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -443 M | -436 M | -424 M | -414 M | -404 M | -395 M | -381 M | -381 M | -369 M | -369 M | -363 M | -348 M | -345 M | -341 M | -330 M | -330 M | -331 M | -331 M | -328 M | -331 M | -332 M | -331 M | -329 M | -329 M | -328 M | -329 M | -327 M | -327 M | -300 M | -285 M | -271 M | -271 M | -252 M | -247 M | -239 M | -239 M | -219 M | -211 M | -203 M | -203 M | -190 M | -184 M | -179 M | -179 M | -170 M | -166 M | -162 M | -162 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -162 M | -443 M | -299 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B |  USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
BioSig Technologies
BSGM
|
-255 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
IRIDEX Corporation
IRIX
|
-79 M | $ 1.35 | - | $ 21.8 M | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
Orthofix Medical
OFIX
|
-368 M | $ 11.72 | -1.26 % | $ 464 M |  Curacao |
 |
LENSAR
LNSR
|
-143 M | $ 5.56 | -8.4 % | $ 64 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
AxoGen
AXGN
|
-307 M | $ 32.61 | 2.71 % | $ 1.5 B | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 36.56 | -0.19 % | $ 1.13 B | USA |
 |
Penumbra
PEN
|
238 M | $ 334.17 | -0.41 % | $ 13 B | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Electromed
ELMD
|
21.2 M | $ 24.7 | 0.86 % | $ 209 M | USA |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
Insulet Corporation
PODD
|
287 M | $ 225.5 | -0.7 % | $ 15.9 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-304 M | $ 0.7 | 3.3 % | $ 38.1 M | USA |
 |
Aethlon Medical
AEMD
|
-168 M | $ 2.16 | -6.09 % | $ 3.37 M | USA |
 |
Profound Medical Corp.
PROF
|
-130 M | $ 5.15 | -4.63 % | $ 180 M | Canada |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Quanterix Corporation
QTRX
|
-577 M | $ 3.82 | -3.05 % | $ 163 M | USA |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 11.48 | 10.7 % | $ 1.55 B | USA |
 |
Myomo
MYO
|
-119 M | $ 0.7 | -1.83 % | $ 29.3 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-374 M | $ 2.4 | -1.64 % | $ 141 M | Israel |
 |
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 3.91 | 4.83 % | $ 146 M |  France |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 15.91 | -3.4 % | $ 373 M | USA |
 |
Outset Medical
OM
|
-1.17 B | $ 3.53 | -2.35 % | $ 53.7 K | USA |
 |
Inspire Medical Systems
INSP
|
-146 M | $ 52.07 | -0.17 % | $ 1.53 B | USA |
 |
Sintx Technologies
SINT
|
-292 M | $ 2.57 | 0.78 % | $ 7.13 M | USA |
 |
Pulmonx Corporation
LUNG
|
-522 M | $ 1.31 | -5.76 % | $ 53.3 M | USA |
 |
Cutera
CUTR
|
-303 M | - | -10.19 % | $ 1.99 M | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Sensus Healthcare
SRTS
|
5.72 M | $ 3.96 | -3.65 % | $ 64.7 M | USA |
 |
InspireMD
NSPR
|
-302 M | $ 1.79 | 3.47 % | $ 115 M | Israel |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
NuVasive
NUVA
|
86.1 M | - | - | $ 2.07 B | USA |
 |
Second Sight Medical Products
EYES
|
-122 M | - | -0.97 % | $ 54.4 M | USA |